<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22368" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Gonorrhea</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Springer</surname>
            <given-names>Charles</given-names>
          </name>
          <aff>SLUNH</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Salen</surname>
            <given-names>Philip</given-names>
          </name>
          <aff>St. Luke's University Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Charles Springer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Philip Salen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22368.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Neisseria gonorrhoeae, an obligate human pathogen, is a sexually transmitted disease that causes consequential worldwide morbidity both in resource-abundant and resource-limited nations, and its diagnosis and treatment require costly expenditures annually. Like other sexually transmitted infections (STIs), gonorrhea disproportionately impacts young adult populations. The obligate pathogen N. gonorrhoeae infects only humans in nature and most commonly manifests as urethritis in men and cervicitis in women. This activity illustrates the presentation, evaluation, and treatment of N. gonorrhoeae and the interprofessional team's role in treating patients, and their partners, with gonococcal infections.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Summarize the etiology of N. gonorrhoeae.</p></list-item><list-item><p>Review the appropriate evaluation of gonorrhea.</p></list-item><list-item><p>Outline the treatment options available for gonorrhea.</p></list-item><list-item><p>Explain the importance of improving care coordination among the interprofessional team to enhance the delivery of care for patients with N. gonorrhoeae infection.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22368&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22368">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22368.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Neisseria gonorrhoeae</italic>, an obligate human pathogen, is a sexually transmitted disease that causes consequential worldwide morbidity both in resource-abundant and resource-limited nations, and its diagnosis and treatment require costly expenditures annually.<xref ref-type="bibr" rid="article-22368.r1">[1]</xref><xref ref-type="bibr" rid="article-22368.r2">[2]</xref>&#x000a0;Like other sexually transmitted infections (STIs), gonorrhea disproportionately impacts young adult populations.<xref ref-type="bibr" rid="article-22368.r3">[3]</xref>&#x000a0;An ancient disease with biblical references (Hebrew Bible; Leviticus 15:1-3), gonorrhea has many slang references, including &#x0201c;the clap,&#x0201d; which likely derived from the name of the ancient Parisian red-light district Les Clapiers.<xref ref-type="bibr" rid="article-22368.r4">[4]</xref></p>
      </sec>
      <sec id="article-22368.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The obligate pathogen <italic toggle="yes">N. gonorrhoeae</italic> infects only humans in nature and most commonly manifests as urethritis in men and cervicitis in women.<xref ref-type="bibr" rid="article-22368.r4">[4]</xref>&#x000a0;Obligate pathogens are bacteria that must manifest disease to facilitate transmission from one host to another. To survive, these bacteria must infect a host and cannot survive outside of a host. Undiagnosed and/or untreated gonorrheal urogenital infections can ascend through the upper urogenital tract and cause many severe reproductive complications, most commonly but not exclusively in women, such as endometritis, pelvic inflammatory disease, infertility, and/or life-threatening morbidity via ectopic pregnancy.<xref ref-type="bibr" rid="article-22368.r5">[5]</xref></p>
      </sec>
      <sec id="article-22368.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>A major public health concern, <italic toggle="yes">N. gonorrhoeae,</italic> is currently the second most common cause of bacterial sexually transmitted infections worldwide.<xref ref-type="bibr" rid="article-22368.r5">[5]</xref>&#x000a0;The World Health Organization (WHO) estimates that 106 million new gonorrhea cases are documented among adults annually worldwide; many more infections go unreported.<xref ref-type="bibr" rid="article-22368.r6">[6]</xref>&#x000a0;With more than 500,000 cases noted annually in the United States, <italic toggle="yes">N. gonorrhoeae</italic> is the second most commonly reported sexually transmitted disease in the United States.<xref ref-type="bibr" rid="article-22368.r1">[1]</xref>&#x000a0;</p>
        <p>Gonorrhea infection has a slight male prevalence secondary to the increased likelihood that males will manifest urogenital symptoms and also due to increased diagnoses among men who have sex with men.<xref ref-type="bibr" rid="article-22368.r1">[1]</xref>&#x000a0;Over the last decade, the incidence of gonorrheal STIs has increased due to the rising number of antibiotic-resistant strains.<xref ref-type="bibr" rid="article-22368.r2">[2]</xref></p>
      </sec>
      <sec id="article-22368.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p><italic toggle="yes">N. gonorrhoeae</italic> infection starts with the adhesion of gonococci to epithelial cells, followed by local cellular invasion. Gonorrhea has multiple surface proteins that facilitate adhesion. <italic toggle="yes">N. gonorrhoeae </italic>utilize pili to initiate adhesion to epithelial cells. Hair-like appendages, pili, cover the bacterial surface. Their ability to lengthen and retract allows the bacteria to attach from a distance and move closer to the epithelial cells, promoting cellular invasion. Pili also provide motility and protection.<xref ref-type="bibr" rid="article-22368.r7">[7]</xref>&#x000a0;Other surface proteins involved in cellular attachment include Opa, opacity-associated proteins, and LOS, lipooligosaccharide. LOS attaches to sperm cells and likely leads to transmission from males to uninfected sexual partners.<xref ref-type="bibr" rid="article-22368.r8">[8]</xref></p>
        <p>Invasion of cervical epithelium involves bacterial cells interacting with host cell complement receptors type 3 (CR3). This communication is initiated by the binding of pili to the CR3.<xref ref-type="bibr" rid="article-22368.r9">[9]</xref> This causes extensive rearrangement of the host cell actin, resulting in large projections called ruffles.<xref ref-type="bibr" rid="article-22368.r10">[10]</xref> Ruffling then allows gonococci to enter host cells in large vacuoles called macropinosomes and subsequently multiply within infected cells.<xref ref-type="bibr" rid="article-22368.r11">[11]</xref></p>
        <p><italic toggle="yes">Neisseria gonorrhoeae </italic>induces localized infection at the anatomic site of inoculation, typically the urethra, cervix, pharynx, or anus in adults and the eye conjunctiva or the pharynx of newborns, but dissemination can occur.<xref ref-type="bibr" rid="article-22368.r6">[6]</xref>&#x000a0;Gonococci are classified as either serum-sensitive or serum-resistant based on their sensitivity to killing by complement activation; serum-resistant strains have the potential to cause disseminated infection.<xref ref-type="bibr" rid="article-22368.r12">[12]</xref>&#x000a0;<italic toggle="yes">N. gonorrhoeae</italic> has evolved multiple mechanisms to combat the innate and adaptive immunity systems of their host organisms&#x02019; immune defenses.<xref ref-type="bibr" rid="article-22368.r4">[4]</xref></p>
      </sec>
      <sec id="article-22368.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Light microscopy of Gram-negative or methylene blue-stained smears of <italic toggle="yes">N. gonorrhoeae</italic> urethral or cervical mucus samples will demonstrate neutrophils with intracellular diplococci. Light microscopy has high sensitivity and specificity for symptomatic males with urethral discharge; however, light microscopy has a lower sensitivity for diagnosing cervical, pharyngeal, and rectal gonorrhea.<xref ref-type="bibr" rid="article-22368.r4">[4]</xref></p>
      </sec>
      <sec id="article-22368.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>In females, <italic toggle="yes">N. gonorrhoeae</italic> most commonly infects the cervix, resulting in cervicitis. When female patients with gonococcal urogenital infections have symptoms, they may complain of vaginal discharge, dysuria, or pelvic pain.<xref ref-type="bibr" rid="article-22368.r1">[1]</xref><xref ref-type="bibr" rid="article-22368.r13">[13]</xref>&#x000a0;Gonorrheal infection of the Bartholin&#x02019;s glands adjacent to the vaginal introitus manifests as labial soft tissue swelling, abscess formation, and pain.<xref ref-type="bibr" rid="article-22368.r14">[14]</xref>&#x000a0;If cervicitis goes undetected and untreated, ascending gonococcal infection can result in upper reproductive tract involvement, such as salpingitis and pelvic inflammatory disease. Pelvic inflammatory disease can manifest with pelvic pain, infertility, and increase the risk of ectopic pregnancy.<xref ref-type="bibr" rid="article-22368.r1">[1]</xref><xref ref-type="bibr" rid="article-22368.r15">[15]</xref>&#x000a0;Gonococcal infections complicating pregnancy can lead to adverse pregnancy outcomes such as low birth weight newborns and transmission to newborns resulting in oropharyngeal or conjunctival infections.<xref ref-type="bibr" rid="article-22368.r15">[15]</xref></p>
        <p>Although more than 50% of females will not manifest symptoms of their gonococcal cervix infections, most males, more than 90%, will manifest urogenital gonorrhea symptomatically.<xref ref-type="bibr" rid="article-22368.r4">[4]</xref><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://paperpile.com/c/6RZG3y/IxRk">[13]</ext-link> The most common clinical manifestations of gonococcal disease in males include penile purulent discharge, dysuria, and testicular discomfort.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://paperpile.com/c/6RZG3y/IxRk">[13]</ext-link> Male urogenital gonococcal complications include orchitis, epididymitis, penile lymphangitis, penile edema, and post-infectious urethral strictures.&#x000a0;The prevalence of rectal and pharyngeal gonococcal infections has been increasing among populations of men who have sex with men.<xref ref-type="bibr" rid="article-22368.r3">[3]</xref></p>
        <p>Like cervicitis, gonococcal infection of the pharynx, the rectum, and the female urethra often present asymptomatically or with subtle symptoms.<xref ref-type="bibr" rid="article-22368.r1">[1]</xref>&#x000a0;If left untreated, gonorrheal infection of the rectum can proceed to manifest with rectal pain, bleeding, discharge, and proctitis.<xref ref-type="bibr" rid="article-22368.r1">[1]</xref>&#x000a0;Uncommonly, <italic toggle="yes">N. gonorrhoeae</italic> manifests systemically as fever/septicemia, tenosynovitis, arthritis, and vasculitis.<xref ref-type="bibr" rid="article-22368.r15">[15]</xref></p>
      </sec>
      <sec id="article-22368.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnostic laboratory assays are essential to confirm the clinical suspicion of gonorrhea. Laboratory confirmation of&#x000a0;<italic toggle="yes">N. gonorrhoeae</italic>&#x000a0;infection is made by direct detection of the gonococcal pathogen in urogenital, anorectal, pharyngeal, or conjunctival swab specimens or first-catch urine.<xref ref-type="bibr" rid="article-22368.r15">[15]</xref>&#x000a0;</p>
        <p>Populations that engage in anogenital sexual intercourse and/or insertive oral sex will require screening for gonorrhea from the anus and pharynx in addition to urogenital screening.<xref ref-type="bibr" rid="article-22368.r3">[3]</xref> Confirmation of the clinical suspicion of gonorrhea is established by detecting <italic toggle="yes">N. gonorrhoeae</italic> or its genetic signature in genital or extragenital samples by light microscopy of stained smears, culture, or nucleic acid amplification tests (NAATs).<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://paperpile.com/c/6RZG3y/rGW1">[4]</ext-link></p>
        <p>The routine utilization of NAATs to screen at-risk asymptomatic patients have demonstrated that pharyngeal and rectal gonococcal infections are not uncommon manifestations.<xref ref-type="bibr" rid="article-22368.r13">[13]</xref>&#x000a0;NAATs are generally more than 95% sensitive and specific in urethral and cervical swabs and first catch urine of males.<xref ref-type="bibr" rid="article-22368.r13">[13]</xref>&#x000a0;</p>
        <p>The development of commercially available point-of-care assays for <italic toggle="yes">N. gonorrhoeae</italic> infection has impacted the time to treatment. However, while these point-of-care assays have few false-positive results, i.e., they demonstrate high levels of specificity, their sensitivity profiles range widely, with false-negative rates varying from 13% to greater than 90%.<xref ref-type="bibr" rid="article-22368.r16">[16]</xref>&#x000a0;Repeat laboratory screening after patient and partner treatment for gonococcal infection enhances eradication efforts.<xref ref-type="bibr" rid="article-22368.r16">[16]</xref>&#x000a0;Recently, the development of multiplex NAATs allows for the screening of an extensive panel of STDs in addition to <italic toggle="yes">N. gonorrhoeae.</italic><xref ref-type="bibr" rid="article-22368.r15">[15]</xref></p>
      </sec>
      <sec id="article-22368.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Empiric therapy for gonococcal infections is often administered during the initial clinical visit based on historical factors such as sexual intercourse with a person with an STI or a clinical exam suspicious of an STI, such as penile drip or abnormal vaginal discharge. Worldwide <italic toggle="yes">N. gonorrhoeae</italic> STI treatment for urogenital infections in males and females most commonly consists of dual therapy with a single intramuscular or intravenous dose of 500 mg ceftriaxone.<xref ref-type="bibr" rid="article-22368.r2">[2]</xref><xref ref-type="bibr" rid="article-22368.r6">[6]</xref>&#x000a0;In patients 150 kg or more, 1 g of ceftriaxone should be given. If the clinician has not ruled out chlamydial infection, then treatment for chlamydia is&#x000a0;with doxycycline 100 mg orally twice a day for seven days unless the patient is pregnant.)</p>
        <p>In Canada, an alternative antimicrobial regimen is favored for first-line <italic toggle="yes">N. gonorrhoeae</italic> treatment of urogenital infections, a single dose of oral cefixime 800 mg paired with a single dose of azithromycin 1 g.<xref ref-type="bibr" rid="article-22368.r6">[6]</xref>&#x000a0;Of note, 2 g of oral azithromycin and 800 mg of oral cefixime have notable gastrointestinal adverse effects, such as vomiting.<xref ref-type="bibr" rid="article-22368.r6">[6]</xref>&#x000a0;Cefixime does not provide as high or sustained bactericidal blood levels as ceftriaxone. It demonstrates limited treatment efficacy for pharyngeal gonorrhea.</p>
        <p>For&#x000a0;complicated gonococcal infections, including pelvic inflammatory disease (PID), epididymitis, and proctitis, dual therapy with a single intramuscular or intravenous dose of 500 mg of ceftriaxone is paired with oral doxycycline 100 mg BID for seven days, rather than a single 1 g dose of azithromycin, because of doxycycline&#x02019;s effectiveness against <italic toggle="yes">C. trachomatis</italic> and documented efficacy in treating epididymitis and proctitis.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://paperpile.com/c/6RZG3y/5z7v">[3]</ext-link> Directly observed therapy, endorsed by the World Health Organization, of gonococcal therapy promotes adherence to therapy and limits treatment failures secondary to noncompliance.<xref ref-type="bibr" rid="article-22368.r17">[17]</xref></p>
        <p><italic toggle="yes">N. gonorrhoeae </italic>has evolved antimicrobial resistance utilized for its treatment since the first use of sulfonamides in the 1930s. In some parts of Asia and Europe, gonococcal isolates exhibiting elevated mean inhibitory concentrations&#x000a0;to ceftriaxone have been identified, and ceftriaxone treatment failures have been reported. When there is a high suspicion or confirmation of <italic toggle="yes">N. gonorrhoeae</italic> resistance to standard therapy based on culture and sensitivity results, treatment of urogenital infection with a single dose of gentamicin 240 mg IM with a single dose of azithromycin 1 g orally can be administered.<xref ref-type="bibr" rid="article-22368.r18">[18]</xref>&#x000a0;</p>
        <p>In patients with a documented life-threatening allergy to cephalosporins or B-lactam allergy, aztreonam monotherapy can be utilized to treat <italic toggle="yes">N. gonorrhoeae</italic> infections. Aztreonam 1 g administered intravenously treats urogenital gonorrhea and may also have efficacy for pharyngeal and rectal gonococcal infection when using a 2 g dose.<xref ref-type="bibr" rid="article-22368.r2">[2]</xref></p>
      </sec>
      <sec id="article-22368.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Urogenital symptoms induced by gonorrhea can be observed with other sexually transmitted diseases, as well as non-sexually transmitted illnesses. Sexually transmitted infections that can cause dysuria, penile discharge, abnormal vaginal discharge, and pelvic pain include <italic toggle="yes">Chlamydia trachomatis</italic>, <italic toggle="yes">Trichomonas vaginalis</italic>, <italic toggle="yes">Treponema pallidum</italic>, <italic toggle="yes">Mycoplasma genitalium,</italic> and herpes simplex virus.<xref ref-type="bibr" rid="article-22368.r3">[3]</xref></p>
        <p>Acute gonococcal infection can impact multiple organ systems. Infectious and noninfectious diseases can cause urethritis, cervicitis, proctitis, conjunctivitis, pharyngitis, and arthritis. Autoimmune, neoplastic, traumatic, and toxicologic etiologies must be considered when evaluating patients presenting with symptoms that raise suspicion of gonorrhea. The gonococcal infection itself can have autoimmune manifestations such as reactive arthritis in association with urethritis and conjunctivitis.<xref ref-type="bibr" rid="article-22368.r1">[1]</xref></p>
      </sec>
      <sec id="article-22368.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Gonorrhea morbidity has risen over the last 20 years, secondary to the progression of antimicrobial resistance.<xref ref-type="bibr" rid="article-22368.r2">[2]</xref></p>
      </sec>
      <sec id="article-22368.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications from gonorrhea result in substantial morbidity and socioeconomic consequences. If gonorrhea infections are not detected or appropriately treated, they can induce serious complications with reproductive health complications in women, including pelvic inflammatory disease, chronic pelvic pain, infertility, first-trimester abortion, and ectopic pregnancy.<xref ref-type="bibr" rid="article-22368.r6">[6]</xref>&#x000a0;Uncommonly, the disseminated gonococcal infection will manifest as septic arthritis or endocarditis. Gonorrheal infection can cause Fitz-Hugh-Curtis syndrome, liver capsule inflammation with resultant intra-abdominal adhesions, in women, and male infertility.</p>
        <p>Complications specific to males include epididymitis, prostatitis, and proctitis.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://paperpile.com/c/6RZG3y/Dd7V">[1]</ext-link> Immune-mediated, systemic complications following gonorrhea infection can result in the triad of reactive arthritis, urethritis, and conjunctivitis.<xref ref-type="bibr" rid="article-22368.r1">[1]</xref>&#x000a0;Gonorrheal infection can complicate obstetrical delivery by infecting newborns via eye contact with genital secretions during the puerperal period and can result in gonococcal conjunctivitis that can progress to blindness. Gonorrheal infection increases the risk of sexual transmission of HIV-AIDS.<xref ref-type="bibr" rid="article-22368.r1">[1]</xref><xref ref-type="bibr" rid="article-22368.r13">[13]</xref></p>
        <p>The development of <italic toggle="yes">N. gonorrhoeae</italic> with antimicrobial resistance is a complication that has societal implications. Generally, the development of antimicrobial resistance corresponds to local, regional, and national antibiotic use; populations in countries such as Holland with lower utilization of cephalosporins, macrolides, and fluoroquinolones have a lower incidence of gonococcal resistance than high antibiotic consumption nations.<xref ref-type="bibr" rid="article-22368.r18">[18]</xref></p>
      </sec>
      <sec id="article-22368.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>When&#x000a0;treating&#x000a0;individuals with suspected or confirmed cephalosporin resistance, clinicians are recommended to consult an infectious disease&#x000a0;consultant and report treatment failure to the Centers for Disease Control within 24 hours of laboratory culture confirmation of the diagnosis of antimicrobial-resistant <italic toggle="yes">N. gonorrhoeae</italic>.<xref ref-type="bibr" rid="article-22368.r18">[18]</xref></p>
      </sec>
      <sec id="article-22368.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Public health control of gonorrhea depends upon suitable antimicrobial therapy in tandem with generalized and targeted prevention interventions, accurate diagnostic assays, partner notification procedures, and epidemiological surveillance. Antibiotic administration should resolve individual cases to decrease the risk of complications and avert further transmission of the infection.<xref ref-type="bibr" rid="article-22368.r4">[4]</xref></p>
        <p>Patients should abstain from sexual activity for at least one week following the initiation of antibiotic therapy. Patients should be counseled regarding the necessity to&#x000a0;microbiologically confirm a cure of <italic toggle="yes">N. gonorrhoeae </italic>if they are treated with alternative therapy if significant comorbidities are present, including HIV, or if symptoms persist. Retesting can provide antibiotic susceptibilities that can avoid further treatment failure. Infected patients with gonorrhea are also at increased risk of contracting other STIs, including HIV. Up to 27% of patients diagnosed with HIV have a diagnosis of gonorrhea within 12 months of HIV diagnosis.<xref ref-type="bibr" rid="article-22368.r19">[19]</xref></p>
      </sec>
      <sec id="article-22368.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The Centers for Disease Control and Prevention advocates for screening pregnant women and women with STI risk factors for <italic toggle="yes">N. gonorrhoeae</italic> infection. STI risk factors include prior STI diagnoses, non-Latino African American ethnicity, young age, sparse condom use, and multitudinous sexual partners.<xref ref-type="bibr" rid="article-22368.r16">[16]</xref></p>
        <p>An interprofessional team of clinicians, epidemiologists, infectious disease specialists, community health nurses, and pharmacists (preferably with infectious disease specialization) can improve patient outcomes. Patients need to be taught preventative measures, and management of recent sex partners (i.e., &#x0003c; 60 days) is also a crucial element in preventing community spread. Nurses and mental health professionals are key players in this type of counseling. Pharmacists will be able to verify dosing and should have knowledge of the latest antimicrobial resistance data and can share that with the clinical staff, in addition to performing medication reconciliation. All interprofessional team members should keep accurate and updated records; these are crucial in the event of drug-resistant infections. The interprofessional approach will help drive the best outcomes with the fewest adverse events. [Level 5]</p>
      </sec>
      <sec id="article-22368.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22368&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22368">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/sexual-health/gonorrhea/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22368">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22368/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22368">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22368.s17">
        <fig id="article-22368.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Gram Stain, dipplococcus, Gonorrhea, Contributed by Dr. James Volk, USCDCP (Public Domain)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="neisseria-gonorrhoeae-the-presence-of-mixed-bacterial-flora-note-the-necrotic-neutrophil-725x494" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22368.s18">
        <fig id="article-22368.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Neisseria gonorrhea (note diplococci) Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gonorrhea" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22368.s19">
        <title>References</title>
        <ref id="article-22368.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Robinette</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Montgomery</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Almonte</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cu-Uvin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lonks</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Chapin</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Kojic</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Hardy</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature.</article-title>
            <source>Infect Dis Obstet Gynecol</source>
            <year>2016</year>
            <volume>2016</volume>
            <fpage>5758387</fpage>
            <pub-id pub-id-type="pmid">27366021</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suay-Garc&#x000ed;a</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Gracia</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Future Prospects for <italic>Neisseria gonorrhoeae</italic> Treatment.</article-title>
            <source>Antibiotics (Basel)</source>
            <year>2018</year>
            <month>Jun</month>
            <day>15</day>
            <volume>7</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29914071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Workowski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bolan</surname>
                <given-names>GA</given-names>
              </name>
              <collab>Centers for Disease Control and Prevention</collab>
            </person-group>
            <article-title>Sexually transmitted diseases treatment guidelines, 2015.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2015</year>
            <month>Jun</month>
            <day>05</day>
            <volume>64</volume>
            <issue>RR-03</issue>
            <fpage>1</fpage>
            <page-range>1-137</page-range>
            <pub-id pub-id-type="pmid">26042815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Unemo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shafer</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>587</fpage>
            <page-range>587-613</page-range>
            <pub-id pub-id-type="pmid">24982323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Unemo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shafer</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>1230</volume>
            <fpage>E19</fpage>
            <page-range>E19-28</page-range>
            <pub-id pub-id-type="pmid">22239555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Unemo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.</article-title>
            <source>BMC Infect Dis</source>
            <year>2015</year>
            <month>Aug</month>
            <day>21</day>
            <volume>15</volume>
            <fpage>364</fpage>
            <pub-id pub-id-type="pmid">26293005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swanson</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Studies on gonococcus infection. IV. Pili: their role in attachment of gonococci to tissue culture cells.</article-title>
            <source>J Exp Med</source>
            <year>1973</year>
            <month>Mar</month>
            <day>01</day>
            <volume>137</volume>
            <issue>3</issue>
            <fpage>571</fpage>
            <page-range>571-89</page-range>
            <pub-id pub-id-type="pmid">4631989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harvey</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Porat</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Jennings</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gibson</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Apicella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Blake</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Gonococcal lipooligosaccharide is a ligand for the asialoglycoprotein receptor on human sperm.</article-title>
            <source>Mol Microbiol</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>1059</fpage>
            <page-range>1059-70</page-range>
            <pub-id pub-id-type="pmid">10844691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edwards</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Uk-Nham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Blake</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Apicella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>A co-operative interaction between Neisseria gonorrhoeae and complement receptor 3 mediates infection of primary cervical epithelial cells.</article-title>
            <source>Cell Microbiol</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>4</volume>
            <issue>9</issue>
            <fpage>571</fpage>
            <page-range>571-84</page-range>
            <pub-id pub-id-type="pmid">12390350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edwards</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Ault</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Apicella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>The role of complement receptor 3 (CR3) in Neisseria gonorrhoeae infection of human cervical epithelia.</article-title>
            <source>Cell Microbiol</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>9</issue>
            <fpage>611</fpage>
            <page-range>611-22</page-range>
            <pub-id pub-id-type="pmid">11553013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edwards</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>JQ</given-names>
              </name>
              <name>
                <surname>Ault</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Apicella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Neisseria gonorrhoeae elicits membrane ruffling and cytoskeletal rearrangements upon infection of primary human endocervical and ectocervical cells.</article-title>
            <source>Infect Immun</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>68</volume>
            <issue>9</issue>
            <fpage>5354</fpage>
            <page-range>5354-63</page-range>
            <pub-id pub-id-type="pmid">10948165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rice</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Molecular basis for serum resistance in Neisseria gonorrhoeae.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>1989</year>
            <month>Apr</month>
            <volume>2 Suppl</volume>
            <issue>Suppl</issue>
            <fpage>S112</fpage>
            <page-range>S112-7</page-range>
            <pub-id pub-id-type="pmid">2497955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirkcaldy</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Harvey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Papp</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Del Rio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Soge</surname>
                <given-names>OO</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Hook</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Kubin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Riedel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zenilman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pettus</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sanders</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sharpe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Torrone</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.</article-title>
            <source>MMWR Surveill Summ</source>
            <year>2016</year>
            <month>Jul</month>
            <day>15</day>
            <volume>65</volume>
            <issue>7</issue>
            <fpage>1</fpage>
            <page-range>1-19</page-range>
            <pub-id pub-id-type="pmid">27414503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhide</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nama</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kalu</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Microbiology of cysts/abscesses of Bartholin's gland: review of empirical antibiotic therapy against microbial culture.</article-title>
            <source>J Obstet Gynaecol</source>
            <year>2010</year>
            <volume>30</volume>
            <issue>7</issue>
            <fpage>701</fpage>
            <page-range>701-3</page-range>
            <pub-id pub-id-type="pmid">20925614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Buder</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The Laboratory Diagnosis of <italic>Neisseria gonorrhoeae</italic>: Current Testing and Future Demands.</article-title>
            <source>Pathogens</source>
            <year>2020</year>
            <month>Jan</month>
            <day>31</day>
            <volume>9</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">32024032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goggins</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Chamberlain</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Jamieson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Haddad</surname>
                <given-names>LB</given-names>
              </name>
            </person-group>
            <article-title>Patterns of Screening, Infection, and Treatment of Chlamydia trachomatis and Neisseria gonorrhea in Pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>135</volume>
            <issue>4</issue>
            <fpage>799</fpage>
            <page-range>799-807</page-range>
            <pub-id pub-id-type="pmid">32168225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walker</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Workowski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Washington</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Soper</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sweet</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Anaerobes in pelvic inflammatory disease: implications for the Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases.</article-title>
            <source>Clin Infect Dis</source>
            <year>1999</year>
            <month>Jan</month>
            <volume>28 Suppl 1</volume>
            <fpage>S29</fpage>
            <page-range>S29-36</page-range>
            <pub-id pub-id-type="pmid">10028108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Unemo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Del Rio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shafer</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century.</article-title>
            <source>Microbiol Spectr</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">27337478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22368.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwarcz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Weinstock</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Louie</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kellogg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lalota</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dickinson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Torian</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wendell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goza</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boyett</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>McCormick</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of persons with recently acquired HIV infection: application of the serologic testing algorithm for recent HIV seroconversion in 10 US cities.</article-title>
            <source>J Acquir Immune Defic Syndr</source>
            <year>2007</year>
            <month>Jan</month>
            <day>01</day>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>112</fpage>
            <page-range>112-5</page-range>
            <pub-id pub-id-type="pmid">17075386</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
